Recent patient studies surrounding the medication Retatrutide , specifically the 120mg formulation branded as ZPHC, suggest a impressive impact on physique decrease and associated health factors. Scientists posit that this dual agonist , affecting both GLP-1 and GIP pathways , may represent a sub